Literature DB >> 22135843

Communicating about alcohol consumption to nonharmful drinkers with Hepatitis C: patient and provider perspectives.

Carol E Blixen1, Noah J Webster, Andrew J Hund, Adam T Perzynski, Stephanie W Kanuch, Eleanor Palo Stoller, Richard A McCormick, Neal V Dawson.   

Abstract

BACKGROUND: Abstaining from alcohol consumption is generally recommended for patients with Hepatitis C(HCV). However, mixed research findings coupled with a lack of consistent guidelines on alcohol consumption and HCV may influence what healthcare providers tell their HCV patients about drinking. This may be more problematic when advising nonharmful drinkers with HCV, a population for whom consumption would not bea problem in the absence of their HCV diagnosis.
OBJECTIVE: This study explores what healthcare providers advise their HCV patients who are drinking alcohol at nonharmful levels about alcohol use and what these patients actually hear.
DESIGN: We conducted separate focus groups and interviews about alcohol use and HCV with nonharmful drinkers with HCV (N=50) and healthcare providers (N=14) at a metropolitan teaching hospital. All focus groups and interviews were audio-taped, transcribed, and analyzed using NVivo, a qualitative data management and analysis program.
RESULTS: We found similar themes about HCV and alcohol consumption (stop completely, occasional drink is ok, cut down, and provision of mixed/ambiguous messages), reported by both providers and patients.Patient respondents who reported hearing “stop completely”were more likely to have had their last medical visit at the gastroenterology (GI) clinic as opposed to the internal medicine (IM) clinic. Furthermore, IM providers were more likely to give their recommendations in“medical language” than were GI providers.
CONCLUSIONS: To make the best health-related decisions about their disease, HCV patients need consistent information about alcohol consumption. Departments of Internal Medicine can increase provider knowledge about HCV and alcohol use by providing more education and training on HCV.

Entities:  

Mesh:

Year:  2008        PMID: 22135843      PMCID: PMC2517959          DOI: 10.1007/s11606-008-0649-2

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  27 in total

Review 1.  National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

Authors: 
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

2.  Estimating future hepatitis C morbidity, mortality, and costs in the United States.

Authors:  J B Wong; G M McQuillan; J G McHutchison; T Poynard
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

3.  Characteristics of online and offline health information seekers and factors that discriminate between them.

Authors:  Shelia R Cotten; Sipi S Gupta
Journal:  Soc Sci Med       Date:  2004-11       Impact factor: 4.634

4.  Detecting alcoholism. The CAGE questionnaire.

Authors:  J A Ewing
Journal:  JAMA       Date:  1984-10-12       Impact factor: 56.272

5.  How many problems do family physicians manage at each encounter? A WReN study.

Authors:  John W Beasley; Terry H Hankey; Rodney Erickson; Kurt C Stange; Marlon Mundt; Marguerite Elliott; Pamela Wiesen; James Bobula
Journal:  Ann Fam Med       Date:  2004 Sep-Oct       Impact factor: 5.166

6.  Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection.

Authors:  Johan Westin; L M Lagging; F Spak; N Aires; E Svensson; M Lindh; A P Dhillon; G Norkrans; R Wejstål
Journal:  J Viral Hepat       Date:  2002-05       Impact factor: 3.728

7.  Alcohol-related discussions during general medicine appointments of male VA patients who screen positive for at-risk drinking.

Authors:  Katharine A Bradley; Amee J Epler; Kristen R Bush; Jennifer L Sporleder; Christopher W Dunn; Nancy E Cochran; Clarence H Braddock; Mary B McDonell; Stephan D Fihn
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

Review 8.  Alcohol and hepatitis C.

Authors:  Kamran Safdar; Eugene R Schiff
Journal:  Semin Liver Dis       Date:  2004-08       Impact factor: 6.115

9.  Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study.

Authors:  C Hézode; I Lonjon; F Roudot-Thoraval; J-M Pawlotsky; E-S Zafrani; D Dhumeaux
Journal:  Aliment Pharmacol Ther       Date:  2003-04       Impact factor: 8.171

10.  Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapy.

Authors:  M Tabone; L Sidoli; C Laudi; S Pellegrino; G Rocca; P Della Monica; M Fracchia; G Galatola; G C Molinaro; S Aricò; A Pera
Journal:  J Viral Hepat       Date:  2002-07       Impact factor: 3.728

View more
  2 in total

1.  Risky alcohol use and serum aminotransferase levels in HIV-infected adults with and without hepatitis C.

Authors:  Judith I Tsui; Debbie M Cheng; Howard Libman; Carly Bridden; Richard Saitz; Jeffrey H Samet
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

2.  Perceptions of Alcohol Risk Among HIV/Hepatitis C Coinfected Patients.

Authors:  Hyang Nina Kim; Abigail Howell; Claire E Blevins; Megan M Pinkston; Debra S Herman; Michael D Stein
Journal:  J Addict Med       Date:  2020 Jul/Aug       Impact factor: 3.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.